Publications by authors named "Junxia Wei"

Claim this Profile
A
A Bispecific Antibody That Targets the Membrane-Proximal Region of Mesothelin and Retains High Anticancer Activity in the Presence of Shed Mesothelin.
Anirban Chakraborty, Masanori Onda, Tara O'Shea, Junxia Wei, Xiufen Liu

Mol Cancer Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing Methodological and Interpretive Concerns in a Systematic Review on Dialysis Experiences of Indigenous Patients in British Colonized Countries.
Junxia Wei, WeiWei Liang, Panpan Liu, Wei Wang

Am J Kidney Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent research and development of inhibitors targeting sentrin-specific protease 1 for the treatment of cancers.
Junxia Wei, Huijing Wang, Qinwen Zheng, Jifa Zhang, Zhichao Chen

Eur J Med Chem· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of inhibitors targeting glycogen synthase kinase-3β for human diseases: Strategies to improve selectivity.
Junxia Wei, Jiaxing Wang, Jifa Zhang, Jinliang Yang, Guan Wang

Eur J Med Chem· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraductal administration of transferrin receptor-targeted immunotoxin clears ductal carcinoma in situ in mouse models of breast cancer-a preclinical study.
Guannan Wang, Alok Kumar, Wanjun Ding, Preethi Korangath, Tapan Bera, Junxia Wei

Proc Natl Acad Sci U S A· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly active CAR T cells that bind to a juxtamembrane region of mesothelin and are not blocked by shed mesothelin.
Xiufen Liu, Masanori Onda, Nathan Watson, Raffit Hassan, Mitchell Ho, Junxia Wei

Proc Natl Acad Sci U S A· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Casein nanoparticles as oral delivery carriers of mequindox for the improved bioavailability.
Li Chen, Junxia Wei, Mengying An, Li Zhang, Shiyu Lin, Wei Zhang

Colloids Surf B Biointerfaces· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity.
Zeliang Zheng, Ryuhei Okada, Hisataka Kobayashi, Tadanobu Nagaya, Junxia Wei

Mol Cancer Ther· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotoxin SS1P is rapidly removed by proximal tubule cells of kidney, whose damage contributes to albumin loss in urine.
Xui-Fen Liu, Junxia Wei, Qi Zhou, Bruce A Molitoris, Ruben Sandoval

Proc Natl Acad Sci U S A· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Mesothelin Recombinant Immunotoxin Therapy for Colorectal Cancer.
Adam Cerise, Tapan K Bera, Xiufen Liu, Junxia Wei, Ira Pastan

Clin Colorectal Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant immunotoxins with albumin-binding domains have long half-lives and high antitumor activity.
Junxia Wei, Tapan K Bera, Xiu Fen Liu, Qi Zhou, Masanori Onda

Proc Natl Acad Sci U S A· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted inhibition of hantavirus replication and intracranial pathogenesis by a chimeric protein-delivered siRNA.
Jie Yang, Ji-Feng Sun, Ting-Ting Wang, Xiao-Hong Guo, Jun-Xia Wei

Antiviral Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of SA12, a novel peptide, on SKBr-3 breast cancer cells via the mitochondrial apoptosis pathway.
Longfei Yang, Ying Cui, Jianjun Shen, Fang Lin, Xi Wang, Junxia Wei

Drug Des Devel Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early growth response gene 1, a TRBP binding protein, is involved in miRNA activity of miR-125a-3p in human cells.
Junxia Wei, Yongri Ouyang, Xia Li, Baoyi Zhu, Jie Yang

Cell Signal· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[miR-141-3p regulates the expression of androgen receptor by targeting its 3'UTR in prostate cancer LNCaP cells].
Chen Wang, Yongri Ouyang, Man Lu, Junxia Wei, Huizhong Zhang

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric ubiquitin ligases inhibit non-small cell lung cancer via negative modulation of EGFR signaling.
Daixing Zhong, Yi Ru, Qinhao Wang, Jing Zhang, Jian Zhang, Junxia Wei

Cancer Lett· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia.
Xi Wang, Jinge Li, Ke Dong, Fang Lin, Min Long, Junxia Wei

Cell Signal· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of microRNA-429 inhibits cell proliferation by targeting p27Kip1 in human prostate cancer cells.
Yongri Ouyang, Ping Gao, Baoyi Zhu, Xi Chen, Fang Lin, Junxia Wei

Mol Med Rep· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rlim, an E3 ubiquitin ligase, influences the stability of Stathmin protein in human osteosarcoma cells.
Xi Chen, Jianjun Shen, Xingyu Li, Xi Wang, Min Long, Junxia Wei

Cell Signal· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy agents-induced immunoresistance in lung cancer cells could be reversed by trop-2 inhibition in vitro and in vivo by interaction with MAPK signaling pathway.
Xi Wang, Min Long, Ke Dong, Fang Lin, Yuanyuan Weng, Junxia Wei

Cancer Biol Ther· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wilms' tumour suppressor gene 1 (WT1) is involved in the carcinogenesis of Lung cancer through interaction with PI3K/Akt pathway.
Xi Wang, Ping Gao, Fang Lin, Min Long, Yuanyuan Weng, Junxia Wei

Cancer Cell Int· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of astrocyte-elevated gene-1 is associated with cervical carcinoma progression and angiogenesis.
Min Long, Ke Dong, Ping Gao, Xi Wang, Li Liu, Junxia Wei

Oncol Rep· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AEG-1 overexpression is essential for maintenance of malignant state in human AML cells via up-regulation of Akt1 mediated by AURKA activation.
Min Long, Miaowang Hao, Ke Dong, Jianjun Shen, Xi Wang, Junxia Wei

Cell Signal· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term and stable correction of uremic anemia by intramuscular injection of plasmids containing hypoxia-regulated system of erythropoietin expression.
Jifeng Sun, Yarong Wang, Jie Yang, Dewei Du, Zhanting Li, Junxia Wei

Exp Mol Med· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum anti-AEG-1 auto-antibody is a potential novel biomarker for malignant tumors.
Xi Chen, Ke Dong, Min Long, Fang Lin, Xi Wang, Junxia Wei

Oncol Lett· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis